Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2

Status

Active not recruiting 6Recruiting 5Unknown 4Withdrawn 3Terminated 2Suspended 1

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 1Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Resectable Esophageal Cancer 1Pleural Mesothelial Neoplasm 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Breast Neoplasms 1

Interventions

pembrolizumab 224Cyclophosphamide 192Radiotherapy 183Nivolumab 180Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 104Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 91Ipilimumab 81Doxorubicin 79Lenalidomide 76durvalumab 75Rituximab 75atezolizumab 72Radiation 72venetoclax 69fludarabine 68Standard of Care 68Gemcitabine 68Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Adjuvants, Immunologic × Clear all
NCT05271630 2026-03-02

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

H. Lee Moffitt Cancer Center and Research Institute

Active not recruiting
69 enrolled
Plasma cell

Multiple Myeloma

NCT04150939 2026-02-17

Cryoablation for the Treatment of Metastatic Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
15 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05307835 2025-12-02

Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Active not recruiting
27 enrolled
Gastrointestinal

Resectable Esophageal Cancer

NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

Mayo Clinic

Phase 1 Active not recruiting
20 enrolled
Thoracic

Pleural Mesothelial Neoplasm

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

M.D. Anderson Cancer Center

Phase NA Active not recruiting
798 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03835520 2023-12-11

Plasma-Target

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase NA Active not recruiting
200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡